

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.54474053 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.54474053 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.19925200 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.19925200 |
| 5 | regulation of transforming growth factor beta1 production (GO:0032908) | 7.09765839 |
| 6 | exogenous drug catabolic process (GO:0042738) | 6.93856478 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.89080800 |
| 8 | omega-hydroxylase P450 pathway (GO:0097267) | 6.66524690 |
| 9 | epoxygenase P450 pathway (GO:0019373) | 6.55556005 |
| 10 | * acute inflammatory response (GO:0002526) | 6.47686993 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.40634655 |
| 12 | tryptophan catabolic process (GO:0006569) | 6.33111072 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 6.33111072 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 6.33111072 |
| 15 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 6.29331080 |
| 16 | positive regulation of glomerulus development (GO:0090193) | 6.10443265 |
| 17 | kynurenine metabolic process (GO:0070189) | 6.10412568 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.94883482 |
| 19 | bile acid biosynthetic process (GO:0006699) | 5.94878090 |
| 20 | chronic inflammatory response (GO:0002544) | 5.79920110 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.72074244 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.71434479 |
| 23 | glyoxylate metabolic process (GO:0046487) | 5.70624199 |
| 24 | urea cycle (GO:0000050) | 5.64612443 |
| 25 | urea metabolic process (GO:0019627) | 5.64612443 |
| 26 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 5.56164061 |
| 27 | complement activation, alternative pathway (GO:0006957) | 5.55622170 |
| 28 | regulation of fibrinolysis (GO:0051917) | 5.54224597 |
| 29 | regulation of protein activation cascade (GO:2000257) | 5.53988558 |
| 30 | protein carboxylation (GO:0018214) | 5.47869849 |
| 31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.47869849 |
| 32 | alpha-linolenic acid metabolic process (GO:0036109) | 5.44717763 |
| 33 | * opsonization (GO:0008228) | 5.35539794 |
| 34 | regulation of humoral immune response (GO:0002920) | 5.31891628 |
| 35 | sulfur amino acid catabolic process (GO:0000098) | 5.19242718 |
| 36 | nitrogen cycle metabolic process (GO:0071941) | 5.18079132 |
| 37 | regulation of complement activation (GO:0030449) | 5.15110027 |
| 38 | cysteine metabolic process (GO:0006534) | 5.13993764 |
| 39 | bile acid metabolic process (GO:0008206) | 5.08952479 |
| 40 | regulation of cholesterol esterification (GO:0010872) | 5.06398542 |
| 41 | flavonoid metabolic process (GO:0009812) | 5.01516189 |
| 42 | serine family amino acid catabolic process (GO:0009071) | 5.00963235 |
| 43 | aromatic amino acid family metabolic process (GO:0009072) | 4.99875581 |
| 44 | reverse cholesterol transport (GO:0043691) | 4.98764874 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 4.91864062 |
| 46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.89148402 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 4.89148402 |
| 48 | macromolecular complex remodeling (GO:0034367) | 4.89148402 |
| 49 | pantothenate metabolic process (GO:0015939) | 4.88644011 |
| 50 | positive regulation of T cell differentiation in thymus (GO:0033089) | 4.88187608 |
| 51 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.84264348 |
| 52 | regulation of apoptotic cell clearance (GO:2000425) | 4.82410722 |
| 53 | tyrosine metabolic process (GO:0006570) | 4.80497971 |
| 54 | phospholipid efflux (GO:0033700) | 4.75766714 |
| 55 | oxidative demethylation (GO:0070989) | 4.71582075 |
| 56 | homocysteine metabolic process (GO:0050667) | 4.67288921 |
| 57 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.66813365 |
| 58 | acylglycerol homeostasis (GO:0055090) | 4.66440345 |
| 59 | triglyceride homeostasis (GO:0070328) | 4.66440345 |
| 60 | negative regulation of sterol transport (GO:0032372) | 4.61382090 |
| 61 | negative regulation of cholesterol transport (GO:0032375) | 4.61382090 |
| 62 | alpha-amino acid catabolic process (GO:1901606) | 4.59611072 |
| 63 | drug metabolic process (GO:0017144) | 4.58019772 |
| 64 | regulation of cell proliferation involved in kidney development (GO:1901722) | 4.56181442 |
| 65 | amino-acid betaine metabolic process (GO:0006577) | 4.50112316 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 4.49783456 |
| 67 | amine catabolic process (GO:0009310) | 4.44241330 |
| 68 | cellular biogenic amine catabolic process (GO:0042402) | 4.44241330 |
| 69 | lysine metabolic process (GO:0006553) | 4.43125004 |
| 70 | lysine catabolic process (GO:0006554) | 4.43125004 |
| 71 | plasma lipoprotein particle clearance (GO:0034381) | 4.40777999 |
| 72 | positive regulation of transforming growth factor beta production (GO:0071636) | 4.40367948 |
| 73 | bile acid and bile salt transport (GO:0015721) | 4.39985224 |
| 74 | transepithelial transport (GO:0070633) | 4.38824879 |
| 75 | coenzyme catabolic process (GO:0009109) | 4.36487437 |
| 76 | cholesterol efflux (GO:0033344) | 4.34691227 |
| 77 | imidazole-containing compound metabolic process (GO:0052803) | 4.31552597 |
| 78 | cellular ketone body metabolic process (GO:0046950) | 4.29948815 |
| 79 | phenylpropanoid metabolic process (GO:0009698) | 4.25475634 |
| 80 | negative regulation of coagulation (GO:0050819) | 4.25347758 |
| 81 | cellular glucuronidation (GO:0052695) | 4.24779867 |
| 82 | glycine metabolic process (GO:0006544) | 4.23814337 |
| 83 | benzene-containing compound metabolic process (GO:0042537) | 4.20623463 |
| 84 | cellular amino acid catabolic process (GO:0009063) | 4.20292359 |
| 85 | fibrinolysis (GO:0042730) | 4.11411922 |
| 86 | glutamate metabolic process (GO:0006536) | 4.11192706 |
| 87 | negative regulation of complement activation (GO:0045916) | 4.10867893 |
| 88 | low-density lipoprotein particle remodeling (GO:0034374) | 4.06693024 |
| 89 | plasma lipoprotein particle assembly (GO:0034377) | 4.06057211 |
| 90 | serine family amino acid metabolic process (GO:0009069) | 4.02965178 |
| 91 | arginine metabolic process (GO:0006525) | 4.01117316 |
| 92 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.99475237 |
| 93 | blood coagulation, intrinsic pathway (GO:0007597) | 3.95919739 |
| 94 | aldehyde catabolic process (GO:0046185) | 3.95630836 |
| 95 | drug catabolic process (GO:0042737) | 3.93978914 |
| 96 | cellular modified amino acid catabolic process (GO:0042219) | 3.93819799 |
| 97 | ethanol oxidation (GO:0006069) | 3.91713756 |
| 98 | negative regulation of blood coagulation (GO:0030195) | 3.90244045 |
| 99 | negative regulation of hemostasis (GO:1900047) | 3.90244045 |
| 100 | regulation of plasminogen activation (GO:0010755) | 3.88617213 |
| 101 | negative regulation of lipase activity (GO:0060192) | 3.87645575 |
| 102 | serine family amino acid biosynthetic process (GO:0009070) | 3.86824138 |
| 103 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.86329020 |
| 104 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.86329020 |
| 105 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.85890926 |
| 106 | regulation of glomerulus development (GO:0090192) | 3.82981990 |
| 107 | cofactor catabolic process (GO:0051187) | 3.82181437 |
| 108 | regulation of acute inflammatory response (GO:0002673) | 3.78851006 |
| 109 | cytolysis (GO:0019835) | 3.78225967 |
| 110 | uronic acid metabolic process (GO:0006063) | 3.77485452 |
| 111 | glucuronate metabolic process (GO:0019585) | 3.77485452 |
| 112 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.77301541 |
| 113 | positive regulation of lipid catabolic process (GO:0050996) | 3.76525587 |
| 114 | * protein activation cascade (GO:0072376) | 3.75695158 |
| 115 | regulation of bile acid biosynthetic process (GO:0070857) | 3.74414552 |
| 116 | phospholipid homeostasis (GO:0055091) | 3.72637079 |
| 117 | ketone body metabolic process (GO:1902224) | 3.71632160 |
| 118 | plasma lipoprotein particle organization (GO:0071827) | 3.71580347 |
| 119 | cholesterol homeostasis (GO:0042632) | 3.71461752 |
| 120 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.70780485 |
| 121 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.70780485 |
| 122 | * complement activation, classical pathway (GO:0006958) | 3.70485959 |
| 123 | * complement activation (GO:0006956) | 3.69966454 |
| 124 | NAD biosynthetic process (GO:0009435) | 3.69415809 |
| 125 | heme transport (GO:0015886) | 3.68063964 |
| 126 | carboxylic acid catabolic process (GO:0046395) | 3.66716081 |
| 127 | organic acid catabolic process (GO:0016054) | 3.66716081 |
| 128 | negative regulation of protein activation cascade (GO:2000258) | 3.66180669 |
| 129 | regulation of cellular extravasation (GO:0002691) | 3.65913953 |
| 130 | sterol homeostasis (GO:0055092) | 3.65250321 |
| 131 | polyketide metabolic process (GO:0030638) | 3.63067134 |
| 132 | doxorubicin metabolic process (GO:0044598) | 3.63067134 |
| 133 | daunorubicin metabolic process (GO:0044597) | 3.63067134 |
| 134 | negative regulation of wound healing (GO:0061045) | 3.62458912 |
| 135 | protein-lipid complex assembly (GO:0065005) | 3.60820544 |
| 136 | * acute-phase response (GO:0006953) | 3.60449687 |
| 137 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.59081054 |
| 138 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176) | 3.48648345 |
| 139 | regulation of transforming growth factor beta production (GO:0071634) | 3.35521342 |
| 140 | arginine catabolic process (GO:0006527) | 3.24178729 |
| 141 | cellular response to ethanol (GO:0071361) | 3.24067612 |
| 142 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.22051348 |
| 143 | detection of bacterium (GO:0016045) | 3.21037075 |
| 144 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.20206404 |
| 145 | primary alcohol catabolic process (GO:0034310) | 3.20042566 |
| 146 | negative regulation of humoral immune response (GO:0002921) | 3.18940872 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.25494808 |
| 2 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.17800003 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.03877301 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.69214005 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.42565176 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.27859774 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.19566945 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.60958787 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.08403754 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.06895419 |
| 11 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.06996881 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03408452 |
| 13 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7786367 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.94477514 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.89926619 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79222222 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.73172827 |
| 18 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.72668361 |
| 19 | TP53_16413492_ChIP-PET_HCT116_Human | 1.71884637 |
| 20 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.66557111 |
| 21 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59940493 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.58198889 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47247359 |
| 24 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.38674666 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.35863266 |
| 26 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.33841677 |
| 27 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.29781857 |
| 28 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.27909363 |
| 29 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.25020017 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24504396 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24468526 |
| 32 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.15835432 |
| 33 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.15294239 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.14303842 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.12008032 |
| 36 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.10797446 |
| 37 | * PHF8_20622853_ChIP-Seq_HELA_Human | 1.10693759 |
| 38 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.07524772 |
| 39 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.07300190 |
| 40 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.05314053 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.04316504 |
| 42 | * NFYA_21822215_ChIP-Seq_K562_Human | 1.03855623 |
| 43 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.03000779 |
| 44 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.03000779 |
| 45 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02644500 |
| 46 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.02248162 |
| 47 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.01610403 |
| 48 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.01441637 |
| 49 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.99539703 |
| 50 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.98756686 |
| 51 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.98623976 |
| 52 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98374325 |
| 53 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97319276 |
| 54 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.96536741 |
| 55 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.94788761 |
| 56 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.94781772 |
| 57 | CJUN_26792858_Chip-Seq_BT549_Human | 0.94404453 |
| 58 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93906800 |
| 59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.93545844 |
| 60 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.93520112 |
| 61 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.93520112 |
| 62 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92648509 |
| 63 | * ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.92186840 |
| 64 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.91994220 |
| 65 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.91670835 |
| 66 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.88135953 |
| 67 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.87444706 |
| 68 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.87189205 |
| 69 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.86944384 |
| 70 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.86090491 |
| 71 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.85810285 |
| 72 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.84129283 |
| 73 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.83728983 |
| 74 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.83408170 |
| 75 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.82794318 |
| 76 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.82708324 |
| 77 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82483311 |
| 78 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.81788068 |
| 79 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.81652248 |
| 80 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.81497206 |
| 81 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.81472988 |
| 82 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.79974437 |
| 83 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79813196 |
| 84 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.79167896 |
| 85 | * ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.78284820 |
| 86 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.76177496 |
| 87 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75314191 |
| 88 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75314191 |
| 89 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.75202973 |
| 90 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.71074019 |
| 91 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70192095 |
| 92 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69390594 |
| 93 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.67934236 |
| 94 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67484631 |
| 95 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67186224 |
| 96 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.66637382 |
| 97 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.64792165 |
| 98 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.63659052 |
| 99 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.62736931 |
| 100 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62294752 |
| 101 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.61222440 |
| 102 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61065718 |
| 103 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.60883455 |
| 104 | AR_20517297_ChIP-Seq_VCAP_Human | 0.58437937 |
| 105 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.58086171 |
| 106 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.58069933 |
| 107 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.57732362 |
| 108 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56235085 |
| 109 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.54346249 |
| 110 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54247559 |
| 111 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.52830116 |
| 112 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52743274 |
| 113 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52113369 |
| 114 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51942950 |
| 115 | CBP_21632823_ChIP-Seq_H3396_Human | 0.51475248 |
| 116 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.50882943 |
| 117 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50478134 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.48869302 |
| 119 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46907774 |
| 120 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.46888465 |
| 121 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.45981143 |
| 122 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.45941447 |
| 123 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.45366312 |
| 124 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.45224400 |
| 125 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.44785978 |
| 126 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.44576955 |
| 127 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.43551176 |
| 128 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43031784 |
| 129 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.41669868 |
| 130 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41481935 |
| 131 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.40510847 |
| 132 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.40134908 |
| 133 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.40030591 |
| 134 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.39434660 |
| 135 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.38751942 |
| 136 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.38006422 |
| 137 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.37846475 |
| 138 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.37836141 |
| 139 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.37769263 |
| 140 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.37485713 |
| 141 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.37051647 |
| 142 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.36910756 |
| 143 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.36805771 |
| 144 | NCOR_22424771_ChIP-Seq_293T_Human | 0.36689205 |
| 145 | GATA2_19941826_ChIP-Seq_K562_Human | 0.36439940 |
| 146 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.36012573 |
| 147 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.35579252 |
| 148 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.35458323 |
| 149 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.35019539 |
| 150 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34866212 |
| 151 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.34772516 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.37213296 |
| 2 | MP0005360_urolithiasis | 7.51775113 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.47681892 |
| 4 | MP0005365_abnormal_bile_salt | 6.23488907 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.11149698 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.14652212 |
| 7 | MP0010386_abnormal_urinary_bladder | 3.94721772 |
| 8 | MP0003252_abnormal_bile_duct | 3.93447974 |
| 9 | MP0003300_gastrointestinal_ulcer | 3.88664845 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.57230778 |
| 11 | MP0009840_abnormal_foam_cell | 3.23431209 |
| 12 | MP0005083_abnormal_biliary_tract | 2.99750711 |
| 13 | MP0003195_calcinosis | 2.88530286 |
| 14 | MP0002163_abnormal_gland_morphology | 2.86351886 |
| 15 | MP0005332_abnormal_amino_acid | 2.72224117 |
| 16 | MP0004043_abnormal_pH_regulation | 2.60480031 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.57172187 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.41943140 |
| 19 | MP0000609_abnormal_liver_physiology | 2.14464688 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 2.14140618 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 2.08592814 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 2.06063603 |
| 23 | MP0002277_abnormal_respiratory_mucosa | 2.05575047 |
| 24 | MP0003868_abnormal_feces_composition | 1.91593137 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.81144408 |
| 26 | MP0001873_stomach_inflammation | 1.78104685 |
| 27 | MP0009697_abnormal_copulation | 1.78035256 |
| 28 | MP0005379_endocrine/exocrine_gland_phen | 1.76837087 |
| 29 | MP0001764_abnormal_homeostasis | 1.68688490 |
| 30 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53990472 |
| 31 | MP0003646_muscle_fatigue | 1.47042744 |
| 32 | MP0003011_delayed_dark_adaptation | 1.40808121 |
| 33 | MP0002089_abnormal_postnatal_growth/wei | 1.40132188 |
| 34 | MP0005451_abnormal_body_composition | 1.39487768 |
| 35 | MP0003656_abnormal_erythrocyte_physiolo | 1.24911462 |
| 36 | MP0003186_abnormal_redox_activity | 1.23940385 |
| 37 | MP0009643_abnormal_urine_homeostasis | 1.21236550 |
| 38 | MP0005647_abnormal_sex_gland | 1.20120930 |
| 39 | MP0009764_decreased_sensitivity_to | 1.17195743 |
| 40 | MP0000598_abnormal_liver_morphology | 1.14214726 |
| 41 | MP0000604_amyloidosis | 1.09071356 |
| 42 | MP0009763_increased_sensitivity_to | 1.06342720 |
| 43 | MP0002254_reproductive_system_inflammat | 1.06336582 |
| 44 | MP0000462_abnormal_digestive_system | 1.06071965 |
| 45 | MP0010368_abnormal_lymphatic_system | 0.96794675 |
| 46 | MP0009785_altered_susceptibility_to | 0.96027275 |
| 47 | MP0005023_abnormal_wound_healing | 0.95524667 |
| 48 | MP0005636_abnormal_mineral_homeostasis | 0.95493207 |
| 49 | MP0008469_abnormal_protein_level | 0.95006307 |
| 50 | MP0003705_abnormal_hypodermis_morpholog | 0.94048132 |
| 51 | MP0000538_abnormal_urinary_bladder | 0.91318330 |
| 52 | MP0009642_abnormal_blood_homeostasis | 0.88610307 |
| 53 | MP0002876_abnormal_thyroid_physiology | 0.87905335 |
| 54 | MP0005408_hypopigmentation | 0.85942698 |
| 55 | MP0005670_abnormal_white_adipose | 0.85804438 |
| 56 | MP0005084_abnormal_gallbladder_morpholo | 0.84127025 |
| 57 | MP0004233_abnormal_muscle_weight | 0.83374970 |
| 58 | MP0001663_abnormal_digestive_system | 0.81325831 |
| 59 | MP0009765_abnormal_xenobiotic_induced | 0.81024047 |
| 60 | MP0001664_abnormal_digestion | 0.79575756 |
| 61 | MP0000613_abnormal_salivary_gland | 0.78765642 |
| 62 | MP0005376_homeostasis/metabolism_phenot | 0.78126051 |
| 63 | MP0002078_abnormal_glucose_homeostasis | 0.75283483 |
| 64 | MP0006036_abnormal_mitochondrial_physio | 0.75274451 |
| 65 | MP0003690_abnormal_glial_cell | 0.73900900 |
| 66 | MP0005220_abnormal_exocrine_pancreas | 0.73492625 |
| 67 | MP0005410_abnormal_fertilization | 0.72310893 |
| 68 | MP0005334_abnormal_fat_pad | 0.69202349 |
| 69 | MP0002971_abnormal_brown_adipose | 0.68771842 |
| 70 | MP0005535_abnormal_body_temperature | 0.66901219 |
| 71 | MP0001661_extended_life_span | 0.66566846 |
| 72 | MP0009278_abnormal_bone_marrow | 0.66488706 |
| 73 | MP0001545_abnormal_hematopoietic_system | 0.66061984 |
| 74 | MP0005397_hematopoietic_system_phenotyp | 0.66061984 |
| 75 | MP0009053_abnormal_anal_canal | 0.62255288 |
| 76 | MP0005464_abnormal_platelet_physiology | 0.61529690 |
| 77 | MP0010234_abnormal_vibrissa_follicle | 0.59957867 |
| 78 | MP0000639_abnormal_adrenal_gland | 0.59666839 |
| 79 | MP0005266_abnormal_metabolism | 0.58863518 |
| 80 | MP0002282_abnormal_trachea_morphology | 0.58691850 |
| 81 | MP0001944_abnormal_pancreas_morphology | 0.58335077 |
| 82 | MP0003943_abnormal_hepatobiliary_system | 0.57854209 |
| 83 | MP0003283_abnormal_digestive_organ | 0.57852216 |
| 84 | MP0004142_abnormal_muscle_tone | 0.57635495 |
| 85 | MP0004130_abnormal_muscle_cell | 0.57472274 |
| 86 | MP0003724_increased_susceptibility_to | 0.55642785 |
| 87 | MP0001756_abnormal_urination | 0.55145189 |
| 88 | MP0003329_amyloid_beta_deposits | 0.54615210 |
| 89 | MP0005381_digestive/alimentary_phenotyp | 0.54249631 |
| 90 | MP0005448_abnormal_energy_balance | 0.53861150 |
| 91 | MP0005025_abnormal_response_to | 0.52591997 |
| 92 | MP0010155_abnormal_intestine_physiology | 0.51332637 |
| 93 | MP0005395_other_phenotype | 0.51212285 |
| 94 | MP0003436_decreased_susceptibility_to | 0.51031316 |
| 95 | MP0002249_abnormal_larynx_morphology | 0.50744010 |
| 96 | MP0006035_abnormal_mitochondrial_morpho | 0.50649036 |
| 97 | MP0002928_abnormal_bile_duct | 0.49950212 |
| 98 | MP0006054_spinal_hemorrhage | 0.47767150 |
| 99 | MP0002822_catalepsy | 0.47643648 |
| 100 | MP0003718_maternal_effect | 0.47573284 |
| 101 | MP0004782_abnormal_surfactant_physiolog | 0.47191905 |
| 102 | MP0005171_absent_coat_pigmentation | 0.46668591 |
| 103 | MP0008874_decreased_physiological_sensi | 0.46175282 |
| 104 | MP0002136_abnormal_kidney_physiology | 0.45241724 |
| 105 | MP0003638_abnormal_response/metabolism_ | 0.45045780 |
| 106 | MP0000343_altered_response_to | 0.44821978 |
| 107 | MP0003866_abnormal_defecation | 0.44242059 |
| 108 | MP0004381_abnormal_hair_follicle | 0.43777441 |
| 109 | MP0005595_abnormal_vascular_smooth | 0.43082109 |
| 110 | MP0008873_increased_physiological_sensi | 0.42789492 |
| 111 | MP0003075_altered_response_to | 0.42260032 |
| 112 | MP0005166_decreased_susceptibility_to | 0.42068934 |
| 113 | MP0003953_abnormal_hormone_level | 0.40100904 |
| 114 | MP0005248_abnormal_Harderian_gland | 0.39362052 |
| 115 | MP0001270_distended_abdomen | 0.39192330 |
| 116 | MP0006082_CNS_inflammation | 0.38030937 |
| 117 | MP0001915_intracranial_hemorrhage | 0.37590165 |
| 118 | MP0000579_abnormal_nail_morphology | 0.37058953 |
| 119 | MP0008872_abnormal_physiological_respon | 0.36296996 |
| 120 | MP0005387_immune_system_phenotype | 0.35852493 |
| 121 | MP0001790_abnormal_immune_system | 0.35852493 |
| 122 | MP0000477_abnormal_intestine_morphology | 0.35091119 |
| 123 | MP0002132_abnormal_respiratory_system | 0.33843160 |
| 124 | MP0002837_dystrophic_cardiac_calcinosis | 0.33773831 |
| 125 | MP0001853_heart_inflammation | 0.33507206 |
| 126 | MP0004883_abnormal_blood_vessel | 0.32862338 |
| 127 | MP0001881_abnormal_mammary_gland | 0.32845798 |
| 128 | MP0000249_abnormal_blood_vessel | 0.32540921 |
| 129 | MP0001845_abnormal_inflammatory_respons | 0.32516017 |
| 130 | MP0002168_other_aberrant_phenotype | 0.31768752 |
| 131 | MP0009115_abnormal_fat_cell | 0.31681481 |
| 132 | MP0001243_abnormal_dermal_layer | 0.29522034 |
| 133 | MP0009384_cardiac_valve_regurgitation | 0.29428182 |
| 134 | MP0000230_abnormal_systemic_arterial | 0.29273590 |
| 135 | MP0009672_abnormal_birth_weight | 0.29221120 |
| 136 | MP0005666_abnormal_adipose_tissue | 0.28605727 |
| 137 | MP0005164_abnormal_response_to | 0.27439301 |
| 138 | MP0002970_abnormal_white_adipose | 0.25714371 |
| 139 | MP0002090_abnormal_vision | 0.22798375 |
| 140 | MP0000427_abnormal_hair_cycle | 0.22706092 |
| 141 | MP0002796_impaired_skin_barrier | 0.22625650 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.45022295 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.38449163 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.33601098 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.83545149 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.67794678 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.39744354 |
| 7 | Xanthomatosis (HP:0000991) | 6.21337409 |
| 8 | Complement deficiency (HP:0004431) | 5.71598485 |
| 9 | Ileus (HP:0002595) | 5.71455462 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 5.64908677 |
| 11 | Rectal prolapse (HP:0002035) | 5.50513348 |
| 12 | Joint hemorrhage (HP:0005261) | 5.05928539 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.79400113 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.71122004 |
| 15 | Hyperammonemia (HP:0001987) | 4.51971237 |
| 16 | Epidermoid cyst (HP:0200040) | 4.49561973 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.40447186 |
| 18 | Hyperglycinemia (HP:0002154) | 4.35957073 |
| 19 | Abnormality of methionine metabolism (HP:0010901) | 4.28371318 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.21263788 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 4.20682510 |
| 22 | Fat malabsorption (HP:0002630) | 4.19113353 |
| 23 | Abnormality of complement system (HP:0005339) | 4.18457970 |
| 24 | Ketosis (HP:0001946) | 4.15898314 |
| 25 | Exocrine pancreatic insufficiency (HP:0001738) | 4.10865419 |
| 26 | Azoospermia (HP:0000027) | 4.10669610 |
| 27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.09118944 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.08712763 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.91097991 |
| 30 | Back pain (HP:0003418) | 3.90655428 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.90489764 |
| 32 | Male infertility (HP:0003251) | 3.87477653 |
| 33 | Abnormality of the intrinsic pathway (HP:0010989) | 3.86127984 |
| 34 | Hypoglycemic coma (HP:0001325) | 3.84850906 |
| 35 | Abnormality of glycine metabolism (HP:0010895) | 3.77208335 |
| 36 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.77208335 |
| 37 | Hyperglycinuria (HP:0003108) | 3.75837141 |
| 38 | Hypercholesterolemia (HP:0003124) | 3.58107050 |
| 39 | Abnormality of the right ventricle (HP:0001707) | 3.47331191 |
| 40 | Spontaneous abortion (HP:0005268) | 3.39922383 |
| 41 | Hyperbilirubinemia (HP:0002904) | 3.32189943 |
| 42 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.25830515 |
| 43 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.23675943 |
| 44 | Steatorrhea (HP:0002570) | 3.21819954 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 3.05566111 |
| 46 | Abnormal spermatogenesis (HP:0008669) | 3.05220180 |
| 47 | Hypochromic microcytic anemia (HP:0004840) | 3.04518868 |
| 48 | Abnormality of serum amino acid levels (HP:0003112) | 3.02946119 |
| 49 | Delayed CNS myelination (HP:0002188) | 3.00266631 |
| 50 | Myocardial infarction (HP:0001658) | 2.98772296 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 2.97034141 |
| 52 | Hepatocellular carcinoma (HP:0001402) | 2.93516925 |
| 53 | Ketoacidosis (HP:0001993) | 2.92532741 |
| 54 | Joint swelling (HP:0001386) | 2.78053842 |
| 55 | Skin nodule (HP:0200036) | 2.72838576 |
| 56 | Metabolic acidosis (HP:0001942) | 2.71933093 |
| 57 | Arthropathy (HP:0003040) | 2.67279731 |
| 58 | Renal tubular acidosis (HP:0001947) | 2.65726682 |
| 59 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.65724329 |
| 60 | Glomerulonephritis (HP:0000099) | 2.65069885 |
| 61 | Vascular calcification (HP:0004934) | 2.63717752 |
| 62 | Abnormality of purine metabolism (HP:0004352) | 2.62800171 |
| 63 | Hypoglycemic seizures (HP:0002173) | 2.59673261 |
| 64 | Lethargy (HP:0001254) | 2.55193587 |
| 65 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.49803236 |
| 66 | Dicarboxylic aciduria (HP:0003215) | 2.49803236 |
| 67 | Gingival bleeding (HP:0000225) | 2.49757384 |
| 68 | Mitral stenosis (HP:0001718) | 2.49360608 |
| 69 | Amyloidosis (HP:0011034) | 2.48118164 |
| 70 | Acanthocytosis (HP:0001927) | 2.47045255 |
| 71 | Abnormality of chloride homeostasis (HP:0011422) | 2.46675343 |
| 72 | Abnormal gallbladder morphology (HP:0012437) | 2.42413457 |
| 73 | Goiter (HP:0000853) | 2.38644423 |
| 74 | Cerebral edema (HP:0002181) | 2.37211895 |
| 75 | Cholelithiasis (HP:0001081) | 2.35558946 |
| 76 | Cardiovascular calcification (HP:0011915) | 2.32888027 |
| 77 | Irritability (HP:0000737) | 2.31608845 |
| 78 | Spastic diplegia (HP:0001264) | 2.31143672 |
| 79 | Neonatal onset (HP:0003623) | 2.29324545 |
| 80 | Gout (HP:0001997) | 2.28329755 |
| 81 | Abnormal gallbladder physiology (HP:0012438) | 2.26663022 |
| 82 | Cholecystitis (HP:0001082) | 2.26663022 |
| 83 | Abnormal pancreas size (HP:0012094) | 2.26633823 |
| 84 | Menorrhagia (HP:0000132) | 2.24638208 |
| 85 | Facial shape deformation (HP:0011334) | 2.23096704 |
| 86 | Potter facies (HP:0002009) | 2.23096704 |
| 87 | Thrombophlebitis (HP:0004418) | 2.21016352 |
| 88 | Abnormality of the Achilles tendon (HP:0005109) | 2.20489753 |
| 89 | Enlarged kidneys (HP:0000105) | 2.17091203 |
| 90 | Esophageal varix (HP:0002040) | 2.16139675 |
| 91 | Pancreatitis (HP:0001733) | 2.15744232 |
| 92 | Malnutrition (HP:0004395) | 2.12212392 |
| 93 | Late onset (HP:0003584) | 2.10903658 |
| 94 | Sensorimotor neuropathy (HP:0007141) | 2.10800177 |
| 95 | Opisthotonus (HP:0002179) | 2.10020452 |
| 96 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.07775817 |
| 97 | Brushfield spots (HP:0001088) | 2.06267678 |
| 98 | Abnormal biliary tract morphology (HP:0012440) | 2.06118348 |
| 99 | Vomiting (HP:0002013) | 2.02495024 |
| 100 | Generalized aminoaciduria (HP:0002909) | 2.01809588 |
| 101 | Abnormality of iron homeostasis (HP:0011031) | 2.00489170 |
| 102 | Poikilocytosis (HP:0004447) | 1.98300153 |
| 103 | Renal cortical cysts (HP:0000803) | 1.97912764 |
| 104 | Abnormality of the gallbladder (HP:0005264) | 1.97885684 |
| 105 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.97417517 |
| 106 | Hemorrhage of the eye (HP:0011885) | 1.97413803 |
| 107 | Hypophosphatemic rickets (HP:0004912) | 1.95915324 |
| 108 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.94816096 |
| 109 | Rickets (HP:0002748) | 1.94670180 |
| 110 | Infertility (HP:0000789) | 1.90869056 |
| 111 | Purpura (HP:0000979) | 1.90197855 |
| 112 | Nephritis (HP:0000123) | 1.85915805 |
| 113 | Spinal muscular atrophy (HP:0007269) | 1.85716377 |
| 114 | Abnormality of proline metabolism (HP:0010907) | 1.83006236 |
| 115 | Hydroxyprolinuria (HP:0003080) | 1.83006236 |
| 116 | Renal tubular dysfunction (HP:0000124) | 1.82857402 |
| 117 | Status epilepticus (HP:0002133) | 1.82762479 |
| 118 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81707966 |
| 119 | Elevated hepatic transaminases (HP:0002910) | 1.81652715 |
| 120 | Elevated alkaline phosphatase (HP:0003155) | 1.80814066 |
| 121 | Alkalosis (HP:0001948) | 1.80192529 |
| 122 | Hyperglycemia (HP:0003074) | 1.77293742 |
| 123 | Glycosuria (HP:0003076) | 1.76233334 |
| 124 | Abnormality of urine glucose concentration (HP:0011016) | 1.76233334 |
| 125 | Abnormality of vitamin metabolism (HP:0100508) | 1.74652722 |
| 126 | Pulmonary embolism (HP:0002204) | 1.72383203 |
| 127 | Recurrent pneumonia (HP:0006532) | 1.66976283 |
| 128 | Hyperuricemia (HP:0002149) | 1.65688947 |
| 129 | Increased purine levels (HP:0004368) | 1.65688947 |
| 130 | Abnormal delivery (HP:0001787) | 1.64062128 |
| 131 | Abnormality of male internal genitalia (HP:0000022) | 1.62971254 |
| 132 | Increased serum ferritin (HP:0003281) | 1.61779226 |
| 133 | Gastrointestinal dysmotility (HP:0002579) | 1.61563905 |
| 134 | Abnormal cartilage morphology (HP:0002763) | 1.59450997 |
| 135 | Increased serum pyruvate (HP:0003542) | 1.56920445 |
| 136 | Abnormality of the anterior horn cell (HP:0006802) | 1.53846980 |
| 137 | Degeneration of anterior horn cells (HP:0002398) | 1.53846980 |
| 138 | Follicular hyperkeratosis (HP:0007502) | 1.51759479 |
| 139 | Infantile muscular hypotonia (HP:0008947) | 1.48527049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.93602001 |
| 2 | FGFR4 | 4.59522350 |
| 3 | ERN1 | 4.40654579 |
| 4 | SIK1 | 4.25150582 |
| 5 | INSRR | 3.44936113 |
| 6 | TAOK3 | 3.35702966 |
| 7 | PRKG2 | 3.07741276 |
| 8 | ERBB4 | 3.05488739 |
| 9 | ZAK | 2.53599221 |
| 10 | MAP2K4 | 2.46748618 |
| 11 | LMTK2 | 14.1454940 |
| 12 | MST1R | 1.99581082 |
| 13 | MAP3K2 | 1.96336646 |
| 14 | PIK3CG | 1.94723992 |
| 15 | MAPK11 | 1.87722165 |
| 16 | TYK2 | 1.75834669 |
| 17 | FLT3 | 1.75282345 |
| 18 | STK39 | 1.75125586 |
| 19 | DAPK2 | 1.70858441 |
| 20 | LATS1 | 1.57398801 |
| 21 | FRK | 1.50216325 |
| 22 | PKN2 | 1.49754213 |
| 23 | NEK9 | 1.48782167 |
| 24 | MAP3K14 | 1.44925576 |
| 25 | ABL2 | 1.39361795 |
| 26 | BMPR1B | 1.36667634 |
| 27 | NLK | 1.36605934 |
| 28 | OXSR1 | 1.35498144 |
| 29 | PTK6 | 1.33036910 |
| 30 | ARAF | 1.24752701 |
| 31 | JAK2 | 1.23204115 |
| 32 | FGFR2 | 1.22491153 |
| 33 | JAK1 | 1.14611593 |
| 34 | TBK1 | 1.14611343 |
| 35 | PINK1 | 1.13599474 |
| 36 | KDR | 1.11105326 |
| 37 | PRKAA2 | 1.11007229 |
| 38 | TRIB3 | 1.09569282 |
| 39 | MAP2K3 | 1.08764665 |
| 40 | STK38L | 1.05452811 |
| 41 | ERBB2 | 1.03083087 |
| 42 | MAP3K7 | 1.03024056 |
| 43 | EPHA3 | 1.02758404 |
| 44 | MAP3K12 | 1.00957212 |
| 45 | MAPK15 | 1.00909622 |
| 46 | ICK | 1.00460101 |
| 47 | IRAK3 | 1.00082441 |
| 48 | MAPK4 | 0.95775700 |
| 49 | GRK6 | 0.92350577 |
| 50 | PRKCZ | 0.91834021 |
| 51 | ROCK1 | 0.90662629 |
| 52 | TIE1 | 0.86690305 |
| 53 | EPHB1 | 0.86222796 |
| 54 | MAPK12 | 0.84957820 |
| 55 | PASK | 0.80467472 |
| 56 | CAMK2G | 0.80201415 |
| 57 | MAP2K6 | 0.79567746 |
| 58 | PNCK | 0.79175182 |
| 59 | MAP3K3 | 0.77560410 |
| 60 | PRKACG | 0.77395617 |
| 61 | MAPK7 | 0.72835424 |
| 62 | TNIK | 0.72806614 |
| 63 | CSK | 0.72097094 |
| 64 | IKBKE | 0.70470166 |
| 65 | PKN1 | 0.70049996 |
| 66 | SGK3 | 0.69702609 |
| 67 | MET | 0.68847595 |
| 68 | MYLK | 0.66835595 |
| 69 | SGK2 | 0.66672786 |
| 70 | MAP3K11 | 0.65794531 |
| 71 | EPHA4 | 0.65454287 |
| 72 | CAMK1D | 0.65026369 |
| 73 | GRK1 | 0.64984382 |
| 74 | GSK3A | 0.64052014 |
| 75 | MAP3K6 | 0.64045897 |
| 76 | TGFBR2 | 0.63545364 |
| 77 | CDK6 | 0.62727221 |
| 78 | FGFR3 | 0.60607915 |
| 79 | DYRK1B | 0.59455322 |
| 80 | PRKAA1 | 0.59254354 |
| 81 | FER | 0.57577069 |
| 82 | TAOK2 | 0.55089637 |
| 83 | PIK3CA | 0.55009037 |
| 84 | CSF1R | 0.54180798 |
| 85 | MAP3K10 | 0.52834532 |
| 86 | PRKCQ | 0.52280205 |
| 87 | MAP3K5 | 0.52266954 |
| 88 | IRAK1 | 0.50858871 |
| 89 | PBK | 0.49814107 |
| 90 | IGF1R | 0.49796253 |
| 91 | MARK3 | 0.48960590 |
| 92 | PRKCG | 0.47926517 |
| 93 | VRK2 | 0.46567699 |
| 94 | PRKG1 | 0.44766206 |
| 95 | SGK494 | 0.43211169 |
| 96 | SGK223 | 0.43211169 |
| 97 | PDPK1 | 0.42804060 |
| 98 | IRAK2 | 0.41513469 |
| 99 | STK38 | 0.41330520 |
| 100 | PTK2 | 0.41036276 |
| 101 | AKT3 | 0.39864812 |
| 102 | FGFR1 | 0.39798364 |
| 103 | MAP3K13 | 0.38726649 |
| 104 | CSNK1G1 | 0.37956038 |
| 105 | TESK2 | 0.37602497 |
| 106 | MAP2K1 | 0.37336933 |
| 107 | RIPK1 | 0.36496013 |
| 108 | CAMK4 | 0.36482204 |
| 109 | MAP3K9 | 0.35772995 |
| 110 | NTRK3 | 0.34992559 |
| 111 | EGFR | 0.34910607 |
| 112 | BRAF | 0.34589603 |
| 113 | MELK | 0.32170701 |
| 114 | PRKCE | 0.31820416 |
| 115 | PRKCA | 0.29628515 |
| 116 | CAMK1G | 0.29015604 |
| 117 | MAP3K1 | 0.28288218 |
| 118 | SIK3 | 0.26872093 |
| 119 | TTK | 0.26714527 |
| 120 | AKT2 | 0.26173655 |
| 121 | NME1 | 0.25938952 |
| 122 | RET | 0.25774519 |
| 123 | CDK4 | 0.25488740 |
| 124 | CHUK | 0.25337757 |
| 125 | SCYL2 | 0.25179263 |
| 126 | ADRBK2 | 0.24879217 |
| 127 | IKBKB | 0.24792475 |
| 128 | KIT | 0.24682616 |
| 129 | BMX | 0.24242480 |
| 130 | PDK1 | 0.23548115 |
| 131 | ABL1 | 0.23519855 |
| 132 | DAPK1 | 0.22194794 |
| 133 | MAPK3 | 0.21860078 |
| 134 | PRKACB | 0.19599793 |
| 135 | PRKACA | 0.19444689 |
| 136 | STK4 | 0.19200301 |
| 137 | ACVR1B | 0.15832334 |
| 138 | MAPKAPK3 | 0.15245545 |
| 139 | EIF2AK1 | 0.15035129 |
| 140 | PIM2 | 0.13842092 |
| 141 | TAF1 | 0.12918841 |
| 142 | BMPR2 | 0.12910638 |
| 143 | STK11 | 0.11361491 |
| 144 | CAMKK2 | 0.10391844 |
| 145 | PRKCB | 0.08523262 |
| 146 | CSNK2A1 | 0.08153389 |
| 147 | CDK9 | 0.06292912 |
| 148 | SRC | 0.05950540 |
| 149 | SGK1 | 0.05926562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.59251763 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.43988561 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.37875311 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33040805 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.03906894 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.93704587 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.71083994 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.66543168 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.53988200 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.51496476 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.41751766 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.33788226 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24933354 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.22521662 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.09856437 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.08780139 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.01726599 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.99225480 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.98976597 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95448534 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.91029524 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.87677919 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84011803 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76229936 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74887470 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.74661491 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73864472 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72804000 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.71438835 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.70254207 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.59671682 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.55163877 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.54509987 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.54173010 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.47529933 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.46673548 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.39404559 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36594290 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32517353 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.28959604 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28867414 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.27687057 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.24069403 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23412615 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23359434 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15226834 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12009856 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.11800746 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.08976794 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.03803512 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.02905028 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.96888257 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96454124 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96113293 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.93537443 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93454723 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89769974 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.78423002 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77758081 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73992948 |
| 61 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.69501505 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67309128 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63469887 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63253577 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51260155 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50132956 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.48869975 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46083364 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.41499103 |
| 70 | Mineral absorption_Homo sapiens_hsa04978 | 0.40389737 |
| 71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.35770133 |
| 72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.32895773 |
| 73 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32876997 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30269616 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28325969 |
| 76 | Malaria_Homo sapiens_hsa05144 | 0.26805405 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23309217 |
| 78 | Tight junction_Homo sapiens_hsa04530 | 0.23274777 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21243526 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.20091826 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.19509932 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18403621 |
| 83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16582021 |
| 84 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16558440 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.15255625 |
| 86 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.08360047 |
| 87 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.07884933 |
| 88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07382639 |
| 89 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.06955505 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2509243 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | -0.2262581 |
| 92 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2208408 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.2178801 |
| 94 | Pertussis_Homo sapiens_hsa05133 | -0.2073926 |
| 95 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2007012 |
| 96 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2002213 |
| 97 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1939142 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1926956 |
| 99 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1915479 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | -0.1532134 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1417656 |
| 102 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1385183 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1379325 |
| 104 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0999537 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0937024 |
| 106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0790185 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0771722 |
| 108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0653544 |
| 109 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0622102 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0590208 |
| 111 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.0502523 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0441153 |
| 113 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0333847 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0239165 |
| 115 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0116193 |
| 116 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0069645 |

